Invesaro

Stocks Health care QUCY

NASDAQ · Health care

Quantum Cyber N.V. (QUCY)

Quantum Cyber N.V. reported revenue of $537.1K in fiscal 2025, down 39.9% from a year earlier. It posted a net loss of $16.2M. In fiscal 2025 capital spending exceeded operating cash flow by $11M. At June 30, 2026 it held $13.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Price
$1.37
+3.01% on the day · September 25, 2026
52-week range $0.30 to $4.93
Market cap
$115.2M
Revenue (FY2025)
$537.1K
-39.9% year on year
Net margin
-3,018.3%

What Quantum Cyber N.V. does

Quantum Cyber N.V. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker QUCY.

Revenue and profit by year

Revenue
FY19: $281.4K $281.4K FY19FY21: $493.6K $493.6K FY21FY21: $577.3K $577.3K FY21FY22: $529.9K $529.9K FY22FY23: $895.5K $895.5K FY23FY24: $894K $894K FY24FY25: $537.1K $537.1K FY25
Net income
FY19: -$957.1K -$957.1K FY19FY21: -$586.9K -$586.9K FY21FY21: -$11.7M -$11.7M FY21FY22: -$26.4M -$26.4M FY22FY23: -$26.3M -$26.3M FY23FY24: -$21.6M -$21.6M FY24FY25: -$16.2M -$16.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$537.1K-$16.1M-$16.2M-$2.70-$11M
2024$894K-$18.8M-$21.6M-$21.91-$17.4M
2023$895.5K-$26.6M-$26.3M-$64.76-$23.1M
2022$529.9K-$26.4M-$26.4M-$74.55-$15.4M
2021$577.3K-$9.7M-$11.7M-$64.93-$3.2M
2021$493.6K-$673.7K-$586.9K-$4.01-$478.4K
Next report expected around October 21, 2026.

Estimated from its filing rhythm: about 68 days after its last report of August 14, 2026, its usual gap. Not a date the company has announced. See the report calendar

Where QUCY ranks in Health care

Revenue$537.1K
#498 of 523 in Health care · Bottom 5%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Quantum Cyber N.V. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 25, 2026
  2. September 25, 2026
  3. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026
  4. August 10, 2026
  5. August 7, 2026
  6. July 24, 2026
  7. July 16, 2026
  8. July 7, 2026
  9. July 1, 2026
  10. June 26, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 12, 2026. Insider transactions on SEC

Insider trades

What the people running Quantum Cyber N.V. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about QUCY

What does Quantum Cyber N.V. do?

Quantum Cyber N.V. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker QUCY.

Is Quantum Cyber N.V. profitable?

No. In fiscal 2025 it reported a net loss of $16.2M on revenue of $537.1K.

How much revenue does Quantum Cyber N.V. make?

In fiscal 2025 Quantum Cyber N.V. reported revenue of $537.1K. That is 39.9% less than a year earlier.

When did Quantum Cyber N.V. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the exhibits from September 25, 2026.

Similar companies

Compare QUCY with

Compare QUCY with any company

Follow QUCY

Get an email when Quantum Cyber N.V. files with the SEC: results, executive changes, material agreements and annual reports.

Follow QUCY: get an email when it files

Where the numbers come from

Financial figures are the values Quantum Cyber N.V. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.